Healthcare / Health Information ServicesKOSDAQ
$8420.00
-130.00 (-1.52%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-12.0B · quality 64.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
23/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$117.9B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-16.0%
↓Gross Margin
97.7%
↑Debt/Equity
0.21
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+61.5%
FCF CAGR
—
FCF margin
-16.5%
FCF / Net income
0.99x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $34.85B · net income $-5.78B · FCF $-5.75B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $34.85B | $34.85B | $25.87B | $13.28B | $8.27B |
| Net Income | $-5.78B | $-5.78B | $-13.02B | $-15.63B | $-15.66B |
| EBITDA | $-3.69B | $-3.69B | $-10.91B | $-13.33B | $-13.92B |
| EPS | -413.00 | -413.00 | -943.00 | -1342.00 | -1383.00 |
| Gross Margin | 97.7% | 97.7% | 96.8% | 91.8% | 89.4% |
| Operating Margin | -14.2% | -14.2% | -48.1% | -118.1% | -185.7% |
| Net Margin | -16.6% | -16.6% | -50.3% | -117.7% | -189.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.21 | 0.21 | 0.37 | 2.16 | 0.63 |
| Current Ratio | 3.55 | 3.55 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-5.75B | $-5.75B | $-11.96B | $-15.93B | $-16.59B |
| Returns | |||||
| ROE | -16.0% | -16.0% | -42.4% | -311.3% | -83.8% |
| Valuation | |||||
| P/B | 3.26 | 3.26 | 11.36 | 85.49 | 4.07 |
| Growth & Yield | |||||
| Revenue Growth | 34.7% | 34.7% | 94.9% | 60.4% | — |
| EPS Growth | 56.2% | 56.2% | 29.7% | 3.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-54.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-943.00 → -413.00
Residual
-54.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.